SG145570A1 - 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents - Google Patents

4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents

Info

Publication number
SG145570A1
SG145570A1 SG200700010-2A SG2007000102A SG145570A1 SG 145570 A1 SG145570 A1 SG 145570A1 SG 2007000102 A SG2007000102 A SG 2007000102A SG 145570 A1 SG145570 A1 SG 145570A1
Authority
SG
Singapore
Prior art keywords
quino
halo
propionic acid
acid derivatives
antineoplastic agents
Prior art date
Application number
SG200700010-2A
Other languages
English (en)
Inventor
Jerome P Horwitz
Thomas H Corbett
Eduardo Palomino
Lisa Polin
Stuart T Hazeldine
Original Assignee
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State filed Critical Univ Wayne State
Publication of SG145570A1 publication Critical patent/SG145570A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG200700010-2A 2002-07-03 2003-07-03 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents SG145570A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39385802P 2002-07-03 2002-07-03

Publications (1)

Publication Number Publication Date
SG145570A1 true SG145570A1 (en) 2008-09-29

Family

ID=30115656

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200700010-2A SG145570A1 (en) 2002-07-03 2003-07-03 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents

Country Status (18)

Country Link
US (3) US7109341B2 (es)
EP (1) EP1539699A1 (es)
JP (1) JP2005532397A (es)
CN (1) CN1688547A (es)
AU (2) AU2003249722A1 (es)
BR (1) BR0311491A (es)
CA (1) CA2491612C (es)
EA (1) EA009679B1 (es)
GE (1) GEP20074058B (es)
IL (1) IL164555A0 (es)
MX (1) MXPA05000233A (es)
NO (1) NO20050573L (es)
NZ (1) NZ535887A (es)
PL (1) PL373624A1 (es)
SG (1) SG145570A1 (es)
UA (1) UA79293C2 (es)
WO (2) WO2004005260A1 (es)
ZA (1) ZA200408191B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000968A (es) * 2001-07-31 2005-02-17 Univ Wayne State Derivados de quinolina y uso de los mismos como agentes antitumor.
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
EP1536789A1 (de) * 2002-08-24 2005-06-08 Zentaris GmbH Arzneimittel enthaltend disorale und ihre derivate und deren anwendung zur behandlung gutartiger und bösartiger tumorerkrankngen
CN100427482C (zh) * 2005-08-01 2008-10-22 复旦大学 N,n-二甲胺酰基-2,3-二呋喃基-6-氨基喹噁啉,其制备方法与应用
US20070054938A1 (en) * 2005-09-07 2007-03-08 Horwitz Jerome P Antitumor agents
US8183379B2 (en) * 2005-09-07 2012-05-22 Wayne State University Antitumor agents
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents
EP1897542A1 (en) * 2006-09-07 2008-03-12 Sanofi-Aventis Aqueous formulation comprising an antitumor agent
WO2008141081A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US9096544B2 (en) 2009-12-23 2015-08-04 Wayne State University Therapeutic compounds
CN103127112A (zh) * 2013-02-27 2013-06-05 江苏先声药物研究有限公司 一类喹啉酮衍生物在肿瘤治疗中的应用
CN105085480B (zh) * 2014-05-16 2017-12-29 湖南大学 2‑[4‑（喹喔啉‑2‑氧基）苯氧基]脂肪酰吡啶胺的医药用途
CN105085506B (zh) * 2014-05-16 2018-01-19 湖南大学 2‑[4‑(苯并噁唑‑2‑氧基)苯氧基]脂肪酰吡啶胺的医药用途
CN107827828B (zh) * 2017-11-21 2021-03-30 南京华漫新材料科技有限公司 含苯酰肼骨架的喹喔啉衍生物及其制备方法和在制备抗肿瘤药物中的应用
CN110698418B (zh) * 2019-09-11 2022-07-01 广西师范大学 一种3-芳胺基喹喔啉-2-甲酰胺类衍生物及其制备方法和应用
TWI826034B (zh) * 2022-10-07 2023-12-11 宏碁股份有限公司 影像過曝改善方法及電子裝置

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54112628A (en) 1978-02-23 1979-09-03 Canon Inc Electromagnetic driving device
JPS6033389B2 (ja) * 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
US5364831A (en) * 1980-08-06 1994-11-15 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US6197728B1 (en) * 1980-08-06 2001-03-06 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US4760066A (en) * 1982-09-21 1988-07-26 Wayne State University Method for treating human tumor cell metastasis
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
US5250690A (en) * 1985-05-02 1993-10-05 Dowelanco Haloalkoxy anilide derivatives of 2-4(-heterocyclic oxyphenoxy)alkanoic or alkenoic acids and their use as herbicides
JPS62190172A (ja) * 1986-02-14 1987-08-20 Teijin Ltd フエノキシ脂肪族カルボン酸誘導体および除草剤
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU5686794A (en) * 1992-12-15 1994-07-04 Du Pont Merck Pharmaceutical Company, The (2-quinoxalinyloxy)phenoxypropanoic acids and related derivatives as anticancer agents
US6680311B1 (en) * 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
JP2001500484A (ja) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー 医薬化合物の製造法
WO1998009988A1 (en) * 1996-09-06 1998-03-12 Eli Lilly And Company Process to prepare pharmaceutical compounds
WO1998017667A1 (en) * 1996-10-18 1998-04-30 Wayne State University 6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice
US6352991B1 (en) * 1997-01-08 2002-03-05 Wayne State University 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
US6238644B1 (en) * 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US6586461B1 (en) * 1998-06-16 2003-07-01 Wayne State University Prenyl transferase inhibitors
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
EP1309579B1 (en) * 2000-05-30 2005-10-12 Board Of Governors Of Wayne State University Inhibitors of matrix metalloproteinases
US6747021B2 (en) * 2000-10-02 2004-06-08 Eli Lilly And Company Cryptophycin compound
MXPA04000968A (es) * 2001-07-31 2005-02-17 Univ Wayne State Derivados de quinolina y uso de los mismos como agentes antitumor.
UA79293C2 (en) 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
, DESIGN, SYNTHESIS AND BIOLOGICAL EVALIATION OF ANALOGUES OF THE ANTI *
PRECLINICAL ANTITUMOR EFFICACY OF ANALOGS XK496:SODIUM-(2-[4-(7-CHLOR *
STUART HAZELDINE ET AL.: "Design, Synthesis and Biological Evaluation of Analogues of the Antitumor Agent, 2-4-(7-Chloro-2-quinoxalinyl)oxyÜphenoxy üpropionic Acid (XK469)" J.MED.CHEM., vol. 44, - 28 April 2001 (2001-04-28) pages 1758-1776 *

Also Published As

Publication number Publication date
AU2003249704A1 (en) 2004-01-23
BR0311491A (pt) 2005-04-26
US7728007B2 (en) 2010-06-01
US7109341B2 (en) 2006-09-19
EA200500095A1 (ru) 2005-06-30
WO2004004651A2 (en) 2004-01-15
MXPA05000233A (es) 2005-04-11
WO2004005260A1 (en) 2004-01-15
PL373624A1 (en) 2005-09-05
US7585863B2 (en) 2009-09-08
CA2491612C (en) 2012-01-03
US20040132618A1 (en) 2004-07-08
IL164555A0 (en) 2005-12-18
JP2005532397A (ja) 2005-10-27
CA2491612A1 (en) 2004-01-15
NZ535887A (en) 2006-11-30
ZA200408191B (en) 2006-07-26
AU2003249704B2 (en) 2010-05-20
EP1539699A1 (en) 2005-06-15
US20090076073A1 (en) 2009-03-19
AU2003249722A1 (en) 2004-01-23
GEP20074058B (en) 2007-03-12
EA009679B1 (ru) 2008-02-28
NO20050573L (no) 2005-02-02
CN1688547A (zh) 2005-10-26
UA79293C2 (en) 2007-06-11
US20060293333A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MXPA05010712A (es) Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias.
GB9914486D0 (en) Medicaments
MX2007004740A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica.
GB0112348D0 (en) Compounds
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
TW200639156A (en) New compounds
GB0109122D0 (en) Novel compounds
EE200000472A (et) Kasvajavastased toimeained
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
ATE424200T1 (de) Solubilisierte topoisomerase-gift-mittel
ATE390923T1 (de) Topoisomerase-giftmittel
SE0401763D0 (sv) Compounds
WO2004014906A3 (en) Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
WO2004044174A3 (en) Topoisomerase-targeting agents
TW200510370A (en) Urea derivatives
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
HK1085744A1 (en) Steroid compounds with anti-tumor activity
TW200744596A (en) Antitumor agents
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"